Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021 at 08:30 AM EST
BOSTON, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced that it will host a virtual Commercial Day for investors on February 11 from 11:30-1:00pm EST.
Presentations will include an overview of the long-term corporate strategy, the global market opportunity in rare pediatric and adult liver disease, and the global commercialization strategy and launch readiness plans for odevixibat in progressive familial intrahepatic cholestasis (PFIC), an ultra-rare pediatric cholestatic liver disease.
The event will be hosted by Ron Cooper, President and Chief Executive Officer and members of Albireo leadership.
Commercial Day Call Details for Thursday, February 11 from 11:30-1:00pm EST
The virtual event will also be accessible from the Albireo Media and Investors page ir.albireopharma.com.
Media & Investor contacts: